Page last updated: 2024-08-17

carbostyril and Severe Combined Immunodeficiency

carbostyril has been researched along with Severe Combined Immunodeficiency in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, Z; Hendler, FJ; Oechsli, MN; Thomas, GR; Van Waes, C	1

Other Studies

1 other study(ies) available for carbostyril and Severe Combined Immunodeficiency

Article	Year
Decreased expression of CD80 is a marker for increased tumorigenicity in a new murine model of oral squamous-cell carcinoma. International journal of cancer, 1999, Jul-30, Volume: 82, Issue:3 Topics: 4-Nitroquinoline-1-oxide; Animals; Animals, Congenic; B7-1 Antigen; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Line, Transformed; Clone Cells; Histocompatibility Antigens Class I; Immunocompetence; Lymphocyte Count; Male; Mice; Mice, Inbred BALB C; Mice, SCID; Mouth Neoplasms; Phenotype; Quinolones; Severe Combined Immunodeficiency	1999

Article

Year

Decreased expression of CD80 is a marker for increased tumorigenicity in a new murine model of oral squamous-cell carcinoma.

International journal of cancer, 1999, Jul-30, Volume: 82, Issue:3

Topics: 4-Nitroquinoline-1-oxide; Animals; Animals, Congenic; B7-1 Antigen; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Line, Transformed; Clone Cells; Histocompatibility Antigens Class I; Immunocompetence; Lymphocyte Count; Male; Mice; Mice, Inbred BALB C; Mice, SCID; Mouth Neoplasms; Phenotype; Quinolones; Severe Combined Immunodeficiency

1999